Drug Shortage Report for NAT-IMATINIB
| Report ID | 236418 |
| Drug Identification Number | 02397293 |
| Brand name | NAT-IMATINIB |
| Common or Proper name | Imatinib |
| Company Name | NATCO PHARMA (CANADA) INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IMATINIB |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 |
| ATC code | L01EA |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-09-01 |
| Actual start date | 2024-09-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-04-21 | French | Compare |
| v4 | 2025-04-21 | English | Compare |
| v3 | 2024-09-02 | English | Compare |
| v2 | 2024-08-30 | French | Compare |
| v1 | 2024-08-30 | English | Compare |
Showing 1 to 5 of 5